Reshma Rangwala

Insider Reports History

Location
Newton, MA
Signature
/s/ Nancy Smith as Attorney-in-Fact for Reshma Rangwala
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Reshma Rangwala:

Company Role Class Num Shares Value Price $ Report Date Ownership
Karyopharm Therapeutics Inc. EVP & Chief Medical Officer Common Stock 29,390 $188,977 $6.43 15 Sep 2025 Direct
Aravive, Inc. Chief Medical Officer Stock Option (Right to buy) 175,000 24 Jan 2022 Direct
Karyopharm Therapeutics Inc. EVP & Chief Medical Officer Stock Option (right to buy) 9,166 28 Feb 2025 Direct

Insider Reports Filed by Reshma Rangwala

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KPTI Karyopharm Therapeutics Inc. 12 Sep 2025 2 -$2,623 4 EVP & Chief Medical Officer 16 Sep 2025, 16:32
KPTI Karyopharm Therapeutics Inc. 23 Apr 2025 1 -$2,585 4 EVP & Chief Medical Officer 24 Apr 2025, 16:40
KPTI Karyopharm Therapeutics Inc. 04 Mar 2025 1 -$22,562 4 EVP & Chief Medical Officer 06 Mar 2025, 16:26
KPTI Karyopharm Therapeutics Inc. 28 Feb 2025 4 $0 4 EVP & Chief Medical Officer 04 Mar 2025, 16:52
KPTI Karyopharm Therapeutics Inc. 22 Apr 2024 1 -$7,943 4 EVP & Chief Medical Officer 23 Apr 2024, 16:02
KPTI Karyopharm Therapeutics Inc. 29 Feb 2024 2 -$25,493 4 EVP & Chief Medical Officer 04 Mar 2024, 19:41
KPTI Karyopharm Therapeutics Inc. 28 Feb 2024 1 $0 4 EVP & Chief Medical Officer 29 Feb 2024, 17:36
KPTI Karyopharm Therapeutics Inc. 24 Jan 2024 1 $0 4 EVP & Chief Medical Officer 25 Jan 2024, 19:16
KPTI Karyopharm Therapeutics Inc. 20 Apr 2023 2 -$27,416 4 EVP & Chief Medical Officer 24 Apr 2023, 18:09
KPTI Karyopharm Therapeutics Inc. 28 Feb 2023 1 $0 4 EVP & Chief Medical Officer 02 Mar 2023, 16:39
KPTI Karyopharm Therapeutics Inc. 29 Apr 2022 2 $0 4 EVP & Chief Medical Officer 02 May 2022, 17:01
KPTI Karyopharm Therapeutics Inc. 19 Apr 2022 0 $0 3 EVP & Chief Medical Officer 29 Apr 2022, 08:45
/report/000143774922001576-rangwala-reshma-2022-01-24 Aravive, Inc. 24 Jan 2022 1 $0 4 Chief Medical Officer 25 Jan 2022, 15:05